COMPOSITION
DL -Tetramisole (except hydrochloride) 5.00 g
Excipient qs 100 ml
PHARMACEUTICAL PROPERTIES
Tetramisole is an anthelmintic from the imidazothiazole family with great activity on the larval and adult forms of gastrointestinal and pulmonary strongles. The mode of action of Tetramisole is linked to muscle paralysis of the parasites. Tetramisole is well absorbed orally, it diffuses well in all tissues which allows it to reach pulmonary nematodes and forms in hypobiosis. Tetramisole is quickly metabolized by the liver and eliminated via the urine and bile.
TARGET SPECIES
Sheep, goats and cattle.
INDICATIONS
Treatment of fascioliasis (F. hepatica), estrosis and nematodoses due to blood-sucking nematodes in ruminants.
ADMINISTRATION AND DOSAGE
Oral use at a dose of 7.5 mg of active ingredient / kg of bodyweight, ie 3 ml of suspension per 10 kg of bodyweight.
CONTRAINDICATIONS AND INTERACTIONS
Do not use in dairy females when milk or its derivatives are intended for human consumption. Beneficial interaction with levamisole and certain benzimidazoles (thiabendazole).
SIDE EFFECTS
At the recommended dose, no side effects are described with rafoxanide
PRECAUTIONS FOR USE
Respect the indicated dosage. Shake well before use. Keep out of the reach of children.
WITHDRAWAL PERIOD
Meat and offal: • Cattle: 14 days. • Sheep and goats: 42 days
STORAGE CONDITIONS
Keep the product in the original packaging,
protect from light and at a temperature ≤ 25 ° C.
PRESENTATIONS
Bottles of 250 ml, 500 ml and 1 liter.